Table 2. The risks of developing cancers in the stroke and control groups.
Characteristics | Stroke | Control | Crude HR$ (95% CI) |
Adjusted HRb (95% CI) |
||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Cancer | #PY | Ratea | N | Cancer | #PY | Ratea | |||
All | 17161 | 1408 | 149263.46 | 9.43 | 68644 | 6763 | 665975.77 | 10.16 | 0.93 (0.88-0.98)* | 0.79 (0.74-0.84)* |
Age | ||||||||||
≦40 | 688 | 22 | 6475.73 | 3.40 | 2752 | 46 | 28976.48 | 1.59 | 2.15 (1.29-3.57)* | 1.79 (0.99-3.23) |
40-60 | 4116 | 276 | 38214.12 | 7.22 | 16464 | 1116 | 166239.69 | 6.71 | 1.08 (0.95-1.23) | 0.90 (0.77-1.05) |
60-80 | 10002 | 975 | 86312.45 | 11.30 | 40008 | 5015 | 382530.71 | 13.11 | 0.86 (0.80-0.92)* | 0.76 (0.71-0.82)* |
>80 | 2355 | 135 | 18261.16 | 7.39 | 9420 | 586 | 88228.89 | 6.64 | 1.08 (090-1.31) | 0.73 (0.60-0.90)* |
Gender | ||||||||||
Male | 10039 | 946 | 85478.29 | 11.07 | 40156 | 4464 | 385779.52 | 11.57 | 0.96 (0.89-1.02) | 0.81 (0.75-0.88) |
Female | 7122 | 462 | 63785.17 | 7.24 | 28488 | 2299 | 280196.25 | 8.21 | 0.88 (0.80-0.98)* | 0.74 (0.67-0.83) |
#PY: person-years.
$HR: hazard ratio.
aRate: per 1000 person-years.
bAdjusted by age groups, gender and comorbidities.
*P-value<0.05.